In the pursuit of genuine anti-inflammatory support, Tidelab™ Australian Abalone Peptides are powered by Abagen®, the world’s first scientifically validated abalone peptide.
This ingredient is the result of a rigorous, long-term commitment to marine biotechnology.
Studies with the Commonwealth Scientific and Industrial Research Organisation (CSIRO) and the Fisheries Research and Development Corporation (FRDC) show Abagen® supports natural inflammatory and joint-health pathways.
The Scientific Foundation
15 Years of Marine Biotechnology
Abagen® is a patent-protected marine peptide developed over 15 years of research in collaboration with Australia's national science agency, the CSIRO (Commonwealth Scientific and Industrial Research Organisation).
Australian Abalone
Derived from premium Australian Blacklip Abalone (Haliotis rubra), the peptide is isolated using advanced nanofiltration technology to guarantee a potent, food-grade, and bioavailable nutrient source. This rigorous process ensures we capture the concentrated elements responsible for the abalone's natural resilience.
Mechanisms of Action
Targeted Inflammatory Modulation
The efficacy of Abagen® stems from its targeted ability to modulate the body's inflammatory signaling pathways at a cellular level. It provides nutritional support that helps regulate systemic inflammation without producing immunosuppressive side effects.
Key pathways supported by Abagen®
Cytokine Regulation
Abagen® has been shown to down-regulate Interleukin-6 (IL-6), a key cytokine strongly associated with chronic inflammation, autoimmune conditions, and age-related tissue degeneration.
Inflammatory Gene Expression
The peptide targets critical inflammatory pathways, including TNF-α and COX-2, helping to maintain the body's natural anti-inflammatory equilibrium.
Preclinical Validation
Research Findings
Independent in-vitro and in-vivo studies have validated the powerful anti-inflammatory potential of Abagen®.
The research demonstrates significant activity against key markers of inflammation:
79% Reduction in Nitric Oxide (NO)
In in vitro macrophage models, Abagen® achieved a significant reduction in Nitric Oxide, a crucial pro-inflammatory mediator that contributes to tissue damage.
50% Reduction in Arthritis Severity
In in vivo testing on models of collagen-induced arthritis (CIA), Abagen® successfully reduced clinical arthritis scores by half, supporting its role in promoting joint recovery and comfort.